COMPANY PROFILE

RedShift BioAnalytics

Provides a next-generation infrared technology with advanced data analytics to facilitate better, faster decision making in biopharmaceutical development from discovery

Boxborough, United StatesFounded 2005Biotech & Life Sciences

Valuation $100–250M Last recorded · 2021

Headcount <100 Current team size

Total funding $50–100M Disclosed equity funding

Unlock exact values

About RedShift BioAnalytics

RedShift BioAnalytics develops and manufactures analytical instruments for the life science and biopharmaceutical sectors. The company's product portfolio, which includes the Aurora, Apollo, and HaLCon systems, is designed to provide critical measurements in the development of protein-based drugs by enabling the structural analysis of biomolecules.

By combining microfluidics with tunable lasers, RedShift BioAnalytics' technology offers a platform for the reliable and accurate detection of changes in molecular structure, which are critical quality attributes that govern the stability and efficacy of protein therapeutics. The company serves research and development laboratories and biopharmaceutical companies, providing them with tools for rapid and precise analysis.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2005
Headquarters: Boxborough, United States
Employees: 26
Open positions: None listed
Dealroom signal: 66.5/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

8 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES EOther financing	Oct 2021	$20M	$80M	Illumina Ventures · Waters Corporation · Technology Venture Partners	—
SERIES DOther financing	Feb 2020	$18M	$72M	Waters Corporation	—

Showing the latest 2 of 8 recorded eventsBook a demo for the full funding history →

Growth signals

RedShift BioAnalytics website traffic

Latest recorded traffic for RedShift BioAnalytics is 3.7K monthly website visits, down 44.8% over the last three months. RedShift BioAnalytics's team declined 18.8% over the past year.

Latest monthly visits3.7K 3-month web change-44.8% 1-year team growth-18.8%

Monthly website visitsOct 2017–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
ABAmber BioA biotechnology company developing a first-of-its-kind RNA writing platform using multi-kilobase edits to reach previously undruggable patient populations, pioneering new gene editing modalities for genetic medicine	San Francisco, United States	Operational	24	$26M	$104M
ABATANIS BiotechAt ATANIS Biotech AG, our mission is to revolutionize the way allergies are diagnosed and thereby to improve treatment success	Oberkirch, Switzerland	Operational
ALABLE LabsAims to contribute to improving human health by providing bio-automated solutions	Incheon, South Korea	Operational
MTMuna TherapeuticsDiscovering and developing transformative therapeutics for neurodegenerative diseases	Copenhagen, Denmark	Operational
STSoley TherapeuticsDrug discovery and development company using cellular responses and AI to identify novel therapies for complex diseases	Brentwood, United States	Operational
GLGlytechGlycan technology for biopharmaceutical drug development	Kyoto, Japan	Operational
RHRheavitaContinuous freeze-drying technology for biopharmaceutical products	Ghent, Belgium	Operational
FTFortis TherapeuticsDeveloping precision therapies for cancer patients	San Diego, United States	Operational